title: Continuous infusion of amphotericin B deoxycholate: does decreased nephrotoxicity couple with time-dependent pharmacodynamics?
authors.forename: Francesco G
authors.initials: FG
authors.lastname: de Rosa
authors.forename: Olivia
authors.initials: O
authors.lastname: Bargiacchi
authors.forename: Sabrina
authors.initials: S
authors.lastname: Audagnotto
authors.forename: Silvia
authors.initials: S
authors.lastname: Garazzino
authors.forename: V Marco
authors.initials: VM
authors.lastname: Ranieri
authors.forename: Giovanni
authors.initials: G
authors.lastname: di Perri
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D003840:Deoxycholic Acid / Q000008:administration & dosage*; D004338:Drug Combinations; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects*; D009181:Mycoses / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination